Back to Search Start Over

Conduction system pacing in France in 2022: A snapshot survey from the Working Group of Pacing and Electrophysiology of the French Society of Cardiology.

Authors :
Ollitrault P
Chaumont C
Font J
Amelot M
Brejoux C
Champ-Rigot L
Ferchaud V
Garcia R
Gomes S
Lebon A
Loiselet P
Martins R
Metais D
Pellissier A
Defaye P
Milliez P
Anselme F
Source :
Archives of cardiovascular diseases [Arch Cardiovasc Dis] 2023 May; Vol. 116 (5), pp. 265-271. Date of Electronic Publication: 2023 May 04.
Publication Year :
2023

Abstract

Background: Conduction system pacing (CSP) is an emerging and promising approach for physiological ventricular pacing. While data from randomized controlled trials are scarce, use of His-bundle pacing (HBP) and left bundle branch area pacing (LBBAP) has increased in France.<br />Aim: To perform a national snapshot survey for cardiac electrophysiologists to evaluate adoption of CSP in France.<br />Methods: An online survey, distributed to every senior cardiac electrophysiologist in France, was conducted in November 2022.<br />Results: A total of 120 electrophysiologists completed the survey. Eighty-three (69%) respondents reported experience in undertaking CSP procedures and 27 (23%) were planning to start performing CSP in the coming 2 years. The implantation techniques and criteria used for successful implantation differed significantly among operators. The most frequent indications for HBP and LBBAP were high-degree atrioventricular block with left ventricular ejection fraction (LVEF) < 40% (24 and 82%, respectively) or with LVEF ≥ 40% (27 and 74%, respectively), and after failure of a coronary sinus left ventricular lead (27 and 71%, respectively). The limitations respondents most frequently perceived when performing HBP were bad sensing/pacing parameters (45%), increased procedure duration (41%) and risk of lead dislodgement (30%). The most frequently perceived limitations to performing LBBAP were absence of guidelines or consensus (31%), lack of medical training (23%) and increased procedure duration (23%).<br />Conclusions: Our national survey-based study supports wide adoption of CSP in France. CSP is currently used as a second-line approach for both antibradycardia and resynchronization indications, with important variations regarding implantation techniques and criteria for measuring success.<br /> (Copyright © 2023 Elsevier Masson SAS. All rights reserved.)

Details

Language :
English
ISSN :
1875-2128
Volume :
116
Issue :
5
Database :
MEDLINE
Journal :
Archives of cardiovascular diseases
Publication Type :
Academic Journal
Accession number :
37179224
Full Text :
https://doi.org/10.1016/j.acvd.2023.04.004